-
1
المؤلفون: Corinne Maréchal, Céleste Lebbé, Lina Benajiba, Jin Huang, Rafael Daltro De Oliveira, Anne Bergeron, Nathalie Langner, Abdennour Chellah, Souhil Allaoua, Jean-Jacques Kiladjian, Juliette Soret-Dulphy, Zineb Ghrieb, Majdi Jebali, Florène François
المصدر: Therapies
مصطلحات موضوعية: 03 medical and health sciences, 0302 clinical medicine, Pharmacology (medical), 030226 pharmacology & pharmacy
-
2
المؤلفون: Jeremy Boussier, Olivier Peyrony, Majdi Jebali, Bruno Charbit, Benjamin Terrier, Nora Kramkimel, Céleste Lebbé, Aurélien Corneau, Magnus Fontes, Jérôme LeGoff, Selim Aractingi, Laetitia Da Meda, Frédéric Rieux-Laucat, Vincent Calmettes, P. Tetu, Olivier Schwartz, Laura Barnabei, Darragh Duffy, Nikaïa Smith, Clara Allayous, Jérôme Hadjadj, Timothée Bruel, Charles Cassius, Nader Yatim, Isabelle Staropoli, F. Herms, Catherine Blanc, Ludivine Grzelak, Barouyr Baroudjian
المساهمون: Immunologie Translationnelle - Translational Immunology lab, Institut Pasteur [Paris]-Université Paris Cité (UPCité), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Sorbonne Université (SU), Virus et Immunité - Virus and immunity, Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Cytometrie et Biomarqueurs – Cytometry and Biomarkers (UTechS CB), Immunogenetics of pediatric autoimmune diseases (Equipe Inserm U1163), Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Cytométrie Pitié-Salpêtrière (PASS-CYPS), Unité Mixte de Service Production et Analyse de données en Sciences de la vie et en Santé (PASS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Université Paris Cité (UPCité), Hôpital Cochin [AP-HP], Laboratoire Roche [Boulogne-Billancourt], Vaccine Research Institute (VRI), Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), N.Y. and C.L. acknowledge grant from the ARC Flash Covid-19 and Cancer call (ONCOVID). N.Y. and D.D. acknowledge grants from the Institut Pasteur for Covid-19 research and the ANR Flash Covid-19 call (CoVarImm). N.S. was supported by an Institut Pasteur Roux Cantarini fellowship. B.T. was supported by the Fonds IMMUNOV, for Innovation in Immunopathology. F.R.-L. acknowledges grants from the ANR Flash Covid-19 (AIROCOVID) and the FAST foundation. The study was also supported by the Institut National de la Santé et de la Recherche Médicale (Inserm) and by government grants managed by the Agence Nationale de la Recherche as part of the 'Investment for the future' program (ANR-10 IAHU-01 and ANR-18-RHUS-0010). L.B. was also supported by the EUR G.E.N.E. (reference #ANR-17-EURE-0013) and is part of the Université de Paris IdEx #ANR-18-IDEX-0001 funded by the French Government through its 'Investments for the future' program., ANR-20-COVI-0053,CoVarImm,Variation de la réponse immune systémique et muqueuse pendant l'infection par le SRAS-CoV-2 et la convalescence(2020), ANR-10-IAHU-0001,Imagine,Institut Hospitalo-Universitaire Imagine(2010), ANR-18-RHUS-0010,ATRACTION,Autoimmunity/inflammation Through Rnaseq Analysis at the single Cell level for Therapeutic Innovation(2018), ANR-17-EURE-0013,GENE,Génétique et Epigénétique Nouvelle Ecole(2017), ANR-18-IDEX-0001,Université de Paris,Université de Paris(2018), Institut Pasteur [Paris] (IP)-Université Paris Cité (UPCité), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Vougny, Marie-Christine, Variation de la réponse immune systémique et muqueuse pendant l'infection par le SRAS-CoV-2 et la convalescence - - CoVarImm2020 - ANR-20-COVI-0053 - COVID-19 - VALID, Instituts Hospitalo-Universitaires - Institut Hospitalo-Universitaire Imagine - - Imagine2010 - ANR-10-IAHU-0001 - IAHU - VALID, Autoimmunity/inflammation Through Rnaseq Analysis at the single Cell level for Therapeutic Innovation - - ATRACTION2018 - ANR-18-RHUS-0010 - RHUS - VALID, Génétique et Epigénétique Nouvelle Ecole - - GENE2017 - ANR-17-EURE-0013 - EURE - VALID, Université de Paris - - Université de Paris2018 - ANR-18-IDEX-0001 - IDEX - VALID, Virus et Immunité - Virus and immunity (CNRS-UMR3569), Vaccine Research Institute [Créteil, France] (VRI), Institut Pasteur [Paris], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Paris (UP)
المصدر: Science Advances
Science Advances, American Association for the Advancement of Science (AAAS), 2021, 7 (34), pp.eabg4081. ⟨10.1126/sciadv.abg4081⟩
Science Advances, 2021, 7 (34), pp.eabg4081. ⟨10.1126/sciadv.abg4081⟩مصطلحات موضوعية: Male, animal diseases, T-Lymphocytes, Adaptive Immunity, CD8-Positive T-Lymphocytes, Antibodies, Viral, Lymphocyte Activation, 0302 clinical medicine, Interferon, Prospective Studies, Immune Checkpoint Inhibitors, Melanoma, Research Articles, 0303 health sciences, Multidisciplinary, Effector, SciAdv r-articles, Middle Aged, Acquired immune system, 3. Good health, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Spike Glycoprotein, Coronavirus, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, medicine.symptom, medicine.drug, Research Article, [SDV.IMM] Life Sciences [q-bio]/Immunology, T cell, Immunology, Inflammation, chemical and pharmacologic phenomena, 03 medical and health sciences, Immune system, medicine, Humans, Health and Medicine, 030304 developmental biology, Aged, business.industry, SARS-CoV-2, COVID-19, biochemical phenomena, metabolism, and nutrition, medicine.disease, Coronavirus, bacteria, business, Immunologic Memory, CD8
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44fcd9ec2801361b1755de9c02fb5050
https://hal-pasteur.archives-ouvertes.fr/pasteur-03334080/file/sciadv.abg4081.pdf -
3
المؤلفون: Marie-Léa, Gauci, Barouyr, Baroudjian, Florian, Herms, Pauline, Tetu, Majdi, Jebali, Nicole, Nicole, Céleste, Lebbé
المصدر: La Revue du praticien. 71(2)
مصطلحات موضوعية: Skin Neoplasms, Humans, Melanoma
URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::ba6b9c447853daef01e4858e419efb54
https://pubmed.ncbi.nlm.nih.gov/34160967 -
4
المؤلفون: Zineb, Ghrieb, Souhil, Allaoua, Jin, Huang, Nathalie, Langner, Florène, François, Corinne, Maréchal, Majdi, Jebali, Céleste, Lebbé, Abdennour, Chellah, Anne, Bergeron, Jean-Jacques, Kiladjian, Rafael, Daltro De Oliveira, Juliette, Soret-Dulphy, Lina, Benajiba
المصدر: Therapie
مصطلحات موضوعية: Clinical Trials as Topic, SARS-CoV-2, COVID-19, COVID-19 pandemic, Recherche Clinique, Early drug development, Pandémie COVID-19, Clinical research, Communicable Disease Control, Lockdown, Humans, Essais cliniques de phase précoce, France, Pandemics, Confinement
-
5
المؤلفون: Cécile Pagès, Raphaël Porcher, Majdi Jebali, Clara Allayous, Nika Madjlessi, R. Amode, A. Kowal, Céleste Lebbé, Manuelle Viguier, Nicole Basset Seguin, J. Roux, Barouyr Baroudjian, Martine Bagot
المصدر: Melanoma Research. 27:110-115
مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Programmed Cell Death 1 Receptor, Ipilimumab, Dermatology, Pembrolizumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Group B, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, Humans, Medicine, 030212 general & internal medicine, Stage (cooking), Adverse effect, Melanoma, Aged, Neoplasm Staging, business.industry, Incidence (epidemiology), Antibodies, Monoclonal, Middle Aged, Surgery, Survival Rate, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Retreatment, Female, Observational study, Immunotherapy, business, Follow-Up Studies, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8128a4b495ae83e78a6b37d9d3b06400
https://doi.org/10.1097/cmr.0000000000000313 -
6
المؤلفون: François-Xavier Danlos, Majdi Jebali, M. Mimoun, Maxime Battistella, Abdellatif Tazi, Barouyr Baroudjian, Martine Bagot, Laetitia Vercellino, Cécile Pagès, Céleste Lebbé
المصدر: Chest. 149:e133-e136
مصطلحات موضوعية: Male, Pulmonary and Respiratory Medicine, Neuroblastoma RAS viral oncogene homolog, Skin Neoplasms, Sarcoidosis, Biopsy, medicine.medical_treatment, Antineoplastic Agents, Ipilimumab, Critical Care and Intensive Care Medicine, 030207 dermatology & venereal diseases, 03 medical and health sciences, 0302 clinical medicine, medicine, Humans, Lymphatic Diseases, Melanoma, Desmoplastic melanoma, Granuloma, business.industry, Mediastinum, Antibodies, Monoclonal, Cancer, Immunotherapy, Middle Aged, medicine.disease, Nivolumab, Head and Neck Neoplasms, Tumor progression, Positron-Emission Tomography, 030220 oncology & carcinogenesis, Immunology, Lymph Nodes, Cardiology and Cardiovascular Medicine, business, medicine.drug
-
7
المؤلفون: Jean-Marc Gornet, Céleste Lebbé, Majdi Jebali, François-Xavier Danlos, Cécile Pagès, Martine Bagot, J. Roux
المصدر: Melanoma research. 25(2)
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Ipilimumab, Dermatology, Antibodies, Monoclonal, Humanized, Immune system, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, CTLA-4 Antigen, Risks and benefits, Adverse effect, Melanoma, business.industry, Antibodies, Monoclonal, Immunotherapy, medicine.disease, Nivolumab, Treatment Outcome, Immune System Diseases, Monoclonal, Steroids, business, medicine.drug
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4ec228690b0694900783ce69713dd15
https://pubmed.ncbi.nlm.nih.gov/25464388
Full Text via ClinicalKey